Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Hans C, Hasselbalch"'
Autor:
Tobias Idor Boklund, Jordan Snyder, Johanne Gudmand-Hoeyer, Morten Kranker Larsen, Trine Alma Knudsen, Christina Schjellerup Eickhardt-Dalbøge, Vibe Skov, Lasse Kjær, Hans C. Hasselbalch, Morten Andersen, Johnny T. Ottesen, Thomas Stiehl
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThe Philadelphia chromosome-negative myeloproliferative neoplasms are a group of slowly progressing haematological malignancies primarily characterised by an overproduction of myeloid blood cells. Patients are treated with various drugs,
Externí odkaz:
https://doaj.org/article/d2e7c2148e984299bb4c140c1200e5d0
Autor:
Marc J. B. Dam, Rasmus K. Pedersen, Trine A. Knudsen, Morten Andersen, Christina Ellervik, Morten Kranker Larsen, Lasse Kjær, Vibe Skov, Hans C. Hasselbalch, Johnny T. Ottesen
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4218-4226 (2023)
Abstract Background Conventional cytoreductive therapy for patients with chronic Philadelphia‐negative myeloproliferative neoplasms (MPNs) includes hydroxyurea (HU), interferon‐alpha2 (IFN), and anagrelide. HU is worldwide the most used cytoreduc
Externí odkaz:
https://doaj.org/article/6d18381c628347d29d0da1bb87b5aa11
Autor:
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiří Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans C. Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian
Publikováno v:
HemaSphere, Vol 7, p e216416f (2023)
Externí odkaz:
https://doaj.org/article/4d7243c8e5154d6eb203cf6a0a30256f
Autor:
Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Tobias Idor Boklund, Morten Andersen, Maria Kefala, Trine A. Knudsen, Christina Schjellerup Eickhardt-Dalbøge, Thomas Stiehl, Johanne Gudmand-Høyer, Jordan Snyder, Morten Holmström, Mads H. Andersen, Johnny T. Ottesen, Christina Ellervik, Hans C. Hasselbalch
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Initial diagnosis of overt myeloproliferative neoplasms (MPNs) represents the juncture during clonal evolution when symptoms or complications prompt an afflicted individual to seek medical attention. In 30-40% of the MPN subgroups essential thrombocy
Externí odkaz:
https://doaj.org/article/ee792f216b2a41bf8a7c41cd3ed8d0cd
Autor:
Sarah F. Christensen, Robyn M. Scherber, Gina L. Mazza, Amylou C. Dueck, Nana Brochmann, Christen L. Andersen, Hans C. Hasselbalch, Ruben A. Mesa, Holly L. Geyer
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Patients with Philadelphia-negative Myeloproliferative Neoplasms (MPN) suffer from numerous symptoms and decreased quality of life. Smoking is associated with an increased symptom burden in several malignancies. The aim of this st
Externí odkaz:
https://doaj.org/article/b165180ffecd468dbab3c975d8ec7b58
Autor:
Arthur E. Frankel, Renuka Reddy, Kayla R. DeSuza, Khaled Deeb, Aaron F. Carlin, Davey Smith, Yushuang Xie, Eknath Naik, Richard T. Silver, Hans C. Hasselbalch
Publikováno v:
Clinical Case Reports, Vol 9, Iss 4, Pp 2228-2235 (2021)
Abstract An 83‐year‐old female had asymptomatic SARS‐CoV‐2 infection while taking ruxolitinib. She remained RT‐PCR positive for viral RNA for >120 days, and Pegylated interferon for 4 weeks led to viral RNA clearance. The observations suppo
Externí odkaz:
https://doaj.org/article/1b3e4bbc4f1d4394b1fe594cfe958103
Autor:
Katrine O. Bangsgaard, Morten Andersen, Vibe Skov, Lasse Kjær, Hans C. Hasselbalch, Johnny T. Ottesen
Publikováno v:
Mathematical Biosciences and Engineering, Vol 17, Iss 6, Pp 7645-7670 (2020)
Heterogeneity of stem cell clones provide a key ingredient in altered hematopoiesis and is of main interest in the study of predisease states as well as in the development of blood cancers such as chronic myeloid leukemia (CML) and the Philadelphia-n
Externí odkaz:
https://doaj.org/article/cc35487e572b4add9d1c02985a112f10
Autor:
Hans C. Hasselbalch, Vibe Skov, Lasse Kjær, Torben L. Sørensen, Christina Ellervik, Troels Wienecke
Publikováno v:
Journal of Neuroinflammation, Vol 17, Iss 1, Pp 1-13 (2020)
Abstract Chronic inflammation and involvement of myeloid blood cells are associated with the development of Alzheimer’s disease (AD). Chronic inflammation is a highly important driving force for the development and progression of the chronic myelop
Externí odkaz:
https://doaj.org/article/5507c948fdcf4ec591250bf03bc8cc03
Autor:
Rasmus K. Pedersen, Morten Andersen, Trine A. Knudsen, Zamra Sajid, Johanne Gudmand‐Hoeyer, Marc J. B. Dam, Vibe Skov, Lasse Kjær, Christina Ellervik, Thomas S. Larsen, Dennis Hansen, Niels Pallisgaard, Hans C. Hasselbalch, Johnny T. Ottesen
Publikováno v:
Cancer Medicine, Vol 9, Iss 6, Pp 2039-2051 (2020)
Abstract Treatment with PEGylated interferon‐alpha2 (IFN) of patients with essential thrombocythemia and polycythemia vera induces major molecular remissions with a reduction in the JAK2V617F allele burden to undetectable levels in a subset of pati
Externí odkaz:
https://doaj.org/article/131ca176f70243be969c1f07922ecf78
Autor:
Vibe Skov, Mads Thomassen, Lasse Kjær, Christina Ellervik, Morten Kranker Larsen, Trine Alma Knudsen, Torben A Kruse, Hans C Hasselbalch
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0270669 (2022)
Chronic inflammation is considered a major driving force for clonal expansion and evolution in the Philadelphia-negative myeloproliferative neoplasms, which include essential thrombocythemia, polycythemia vera and primary myelofibrosis (MPNs). One of
Externí odkaz:
https://doaj.org/article/aceab8411aa04d0da74a523ba9142672